Question · Q3 2025
Upal Dhananjay Rana requested color on the current state of demand for life science leasing and supply across BXP's markets, given recent softer commentary from peers, and BXP's outlook for the industry.
Answer
Owen Thomas (CEO, BXP Inc) explained that BXP's life science exposure is primarily in Boston's urban edge and a joint venture in South San Francisco. He described demand for wet lab space as 'pretty tepid,' with some inquiry but no major transactions close at the South San Francisco building. He noted 180,000 square feet of first-generation space available in Boston's urban edge.